Detalhe da pesquisa
1.
Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment.
Clin Infect Dis
; 67(suppl_3): S303-S307, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30496466
2.
d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.
Clin Infect Dis
; 67(suppl_3): S308-S316, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30496460
3.
Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45].
J Mass Spectrom Adv Clin Lab
; 25: 72, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36035622
4.
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.
Clin Mass Spectrom
; 14 Pt A: 34-45, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34934812